Viral suppression is comparable with 0.5 mg and 1.0 mg daily doses of entecavir in treatment-naive HBV-related decompensated cirrhosis.

Goel, Amit; Rungta, Sumit; Verma, Prashant; Verma, Abhai; Verma, Ajay Narayan; Rai, Praveer; Aggarwal, Rakesh

Goel, Amit; Rungta, Sumit; Verma, Prashant; Verma, Abhai; Verma, Ajay Narayan; Rai, Praveer; Aggarwal, Rakesh.

Afiliación

Goel A; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Rungta S; Department of Gastroenterology, King George's Medical University, Lucknow, India.
Verma P; Department of Gastroenterology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India.
Verma A; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Verma AN; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Rai P; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Aggarwal R; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Antivir Ther ; 25(5): 267-273, 2020.

Article en En | MEDLINE | ID: mdl-33404519

Asunto(s)

Virus de la Hepatitis B; Hepatitis B Crónica; Antivirales/uso terapéutico; ADN Viral; Guanina/análogos & derivados; Antígenos e de la Hepatitis B; Virus de la Hepatitis B/genética; Hepatitis B Crónica/complicaciones; Hepatitis B Crónica/tratamiento farmacológico; Humanos; Cirrosis Hepática/tratamiento farmacológico; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis B / Hepatitis B Crónica Límite: Humans Idioma: En Revista: Antivir Ther Asunto de la revista: TERAPIA POR MEDICAMENTOS / VIROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google